Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR
Circulating tumor DNA (ctDNA) analysis has clinical utility in EGFR mutant NSCLC. Circulating tumor cells (CTCs) consist a unique source of information at the cellular level. Digital PCR (dPCR) is a valuable tool for accurate and valid analysis of gene mutations in liquid biopsy analysis. In the pre...
Main Authors: | Aliki Ntzifa, Athanasios Kotsakis, Vassilis Georgoulias, Evi Lianidou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2736 |
Similar Items
-
DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment
by: Aliki Ntzifa, et al.
Published: (2021-11-01) -
PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC)
by: Evangelia Pantazaka, et al.
Published: (2022-08-01) -
Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy
by: Galatea Kallergi, et al.
Published: (2022-03-01) -
Blood sample as a promising diagnostic tool in oncology - literature review
by: Dominik Drobek, et al.
Published: (2023-06-01) -
Erratum: Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
by: Frontiers Production Office
Published: (2023-03-01)